Secondary analyses considered the association of selective cox-@ inhibitors ( eg , celecoxib ) , nonselective agents with cox-@ > cox-@ inhibition ( eg , naproxen ) , and nonselective agents with cox-@ > cox-@ inhibition ( eg , ibuprofen ) with the primary outcome .